Preparation of the Multifunctional Liposome-Containing Microneedle Arrays as an Oral Cavity Mucosal Vaccine Adjuvant-Delivery System

Author(s):  
Ting Wang ◽  
Ning Wang
2010 ◽  
Vol 9 (4) ◽  
pp. 431-440 ◽  
Author(s):  
Girishchandra B Patel ◽  
Wangxue Chen

2018 ◽  
Vol 14 (5) ◽  
pp. 1745
Author(s):  
Ning Wang ◽  
Xueting Wang ◽  
Yuanyuan Zhen ◽  
Ning Li ◽  
Shaohong Jiang ◽  
...  

2016 ◽  
Vol 12 (8) ◽  
pp. 2075-2089 ◽  
Author(s):  
Xueting Wang ◽  
Ning Wang ◽  
Ning Li ◽  
Yuanyuan Zhen ◽  
Ting Wang

mSphere ◽  
2018 ◽  
Vol 3 (4) ◽  
Author(s):  
John D. Clements ◽  
Elizabeth B. Norton

ABSTRACTPerhaps the best-studied mucosal adjuvants are the bacterially derived ADP-ribosylating enterotoxins. This adjuvant family includes heat-labile enterotoxin ofEscherichia coli(LT), cholera toxin (CT), and mutants or subunits of LT and CT. These proteins promote a multifaceted antigen-specific response, including inflammatory Th1, Th2, Th17, cytotoxic T lymphocytes (CTLs), and antibodies. However, more uniquely among adjuvant classes, they induce antigen-specific IgA antibodies and long-lasting memory to coadministered antigens when delivered mucosally or even parenterally. The purpose of this minireview is to describe the general properties, history and creation, preclinical studies, clinical studies, mechanisms of action, and considerations for use of the most promising enterotoxin-based adjuvant to date, LT(R192G/L211A) or dmLT. This review is timely due to completed, ongoing, and planned clinical investigations of dmLT in multiple vaccine formulations by government, nonprofit, and industry groups in the United States and abroad.


Sign in / Sign up

Export Citation Format

Share Document